FDA Inspection 1269495 - Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. - April 11, 2025

Record Details

This FDA Inspection record concerns Evonik Rexim (Nanning) Pharmaceutical Co. Ltd., with an inspection on April 11, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.
Inspection Date: April 11, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations

Open in Dashboard

ID · 7c48315b-f6d9-4a32-91c8-355b8b0ea9ed